Alphatec Holdings Inc. (ATEC), a leading medical equipment and supplies company, witnessed a significant surge in its stock price, soaring over 5% in pre-market trading on Thursday. This rally was fueled by the company's impressive fourth-quarter 2024 financial results and an optimistic outlook for the upcoming year.

In the fourth quarter of 2024, Alphatec achieved remarkable growth, with total revenue reaching $177 million, representing a 28% year-over-year increase and a 17% sequential growth. The company's surgical revenue grew by an impressive 28% year-over-year to $157 million, while its EOS revenue rose by 32% to $20 million. Furthermore, Alphatec reported positive free cash flow of $9 million for the first time since its transformation, a significant milestone for the company.

Looking ahead to 2025, Alphatec provided an optimistic revenue outlook, projecting approximately $732 million in revenue, reflecting a robust 20% growth rate. Additionally, the company forecasted an adjusted EBITDA of $75 million for the upcoming year. These positive financial projections, combined with the strong fourth-quarter performance, fueled investor confidence and drove the pre-market surge in Alphatec's stock price.